電子版完整信息   [更多]

要求： 1. HS編碼30049090.90 2. 年份：2011-2015   [更多]

標(biāo)題： 1、Prostanoids for chronic critical leg ischemia. A randomized, controlled, open-label trial with prostaglandin E1. The ICAI Study Group. Ischemia Cronica degli Arti Inferiori. 2、Removal ofcysteinylation from an unpaired sulfhydryl in the variable regionof a recombinant monoclonal IgG1 antibody improves homogeneity，stability，and biological activity 3、Pharmacokinetics of fixed-dose combination of tenofovir disoproxil fumarate, lamivudine, and efavirenz: results of a randomized, crossover, bioequivalence study。 4、Synthesis and biological evaluation of bis(methoxymethyl)-7,8-dihydro-[1,4]dioxino[2,3-g]quinazolines as EGFR tyrosine kinase inhibitors. Lee, Yong Sup; Seo, Seon Hee;Yang, Beom-Seok; Lee, Jae Yeol Archiv der Pharmazie (Weinheim,Germany) Volume 338 Issue 10 Pages 502-505 Journal 2005 5、Fluorine-18 labeling of 6,7-disubstituted anilinoquinazoline derivatives for positron emission tomography (PET) imaging of tyrosine kinase receptors: Synthesis of 18FIressa and related molecular probes. Seimbille, Yann; Phelps, Michael E.; Czernin, Johannes; Silverman, Daniel H. S. Journal of Labelled Compounds & Radiopharmaceuticals Volume 48 Issue 11 Pages 829-843 Journal 2005 6、 Kinetic study of a 2-hydroxypropyl - -cyclodextrin-based formulation of all -trans-retinoic acid in Sprague-Dawley rats after oral or intravenous administration. Lin HS,Chan SY,Low KS,et al. Journal of Pharmacological Sciences . 2000 7、 Design and in vivo testing of 17-beta estradial -HP beta CD sublingual tablets. Fridriksdottir H,Loftsson T,Gudmundsson JA,et al. Pharmazie . 1996 8、 Hydroxypropyl - -cyclodextrin derivatives: influence of average degree of substitution on complexing ability and surface activity. Muller BW,Brauns U. Journal of Pharmacological Sciences . 1986 9、 Cyclodextrins as co-enhancers in dermal and transdermal drug delivery. Loftsson T,Masson M,Sigurdsson HH,et al. Pharmazie . 1998 10、 Effect of 2hydroxypropyl - -cyclodextrin on percutaneous absorption   [更多]

求購(gòu)歐洲藥典EP9.0中關(guān)于腺相關(guān)病毒的章節(jié)內(nèi)容   [更多]

本人急需最新版美國(guó)英國(guó)歐洲日本藥典目錄,懇求手上有資源的同志可以發(fā)給我,多謝!!!   [更多]

高價(jià)求購(gòu)《預(yù)充式導(dǎo)管沖洗器》相關(guān)信息，內(nèi)容要清晰，價(jià)格好商量。。。。   [更多]

標(biāo)題： 1、Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial 2、Management of hypertension with the fixed combination of perindopril and amlodipine in daily clinical practice: results from the STRONG prospective, observational, multicenter study 3、Bioequivalence study of two perindopril erbumine tablet formulations in healthy volunteers 4、Development and in vitro/in vivo evaluation of immediate release perindopril tablets 5、The advantages of combination therapy on hypertension: development of immediate release perindoprilindapamide tablet and assessment of bioequivalence studies 6、Does Chinese ethnicity affect the pharmacokinetics and pharmacodynamics of angiotensin-converting enzyme inhibitors? - PubMed - NCBI 7、Drug Dev Ind Pharm. 2013 Jul;39(7):996-1004. doi: 10.3109/03639045.2012.689765. Epub 2012 May 25. A potent preparation method combining neutralization with microfluidization for rebamipide nanosuspensions and its in vivo evaluation. Shi Y1, Zou M, An Y, Ji Z, Gao P, Cheng G. 8、Drug Dev Ind Pharm. 2006 Jul;32(6):651-60. Production of an extremly low dose procaterol HCl preparation by fluidized-bed coating method: in vitro and in vivo evaluation. Yu TW1, Chen RR, Gau CS. 9、Enhancement of solubility and dissolution of cilostazol by solid dispersion technique. Park JH, Choi HK. Arch Pharm Res. 2015 Jul;38(7):1336-44. doi: 10.1007/s12272-014-0547-6. Epub 2015 Jan 8. 10、Solid-state amorphization of rebamipide and investigation on solubility and stability of the amorphous form. Xiong X, Xu K, Li S, Tang P, Xiao Y, Li H. Drug Dev Ind Pharm. 2017 Feb;43(2):283-292. doi: 10.1080/03639045.2016.1239627. Epub 2016 Oct 6. 要求：將符合要求的文獻(xiàn)PDF格式打包上傳   [更多]

求購(gòu)“USP Monographs: Mycophenolate Mofetil for Injection”《 USP41-NF36 》的藥典標(biāo)準(zhǔn)一份.   [更多]

目的: 了解三苯基膦的研究背景、合成方法、圖譜 關(guān)鍵詞: 三苯基膦 化合物CA登記號(hào)(CAS): 603-35-0   [更多]

1產(chǎn)后康復(fù)。2盆底治療。3保宮護(hù)宮。   [更多]